Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 23, 2022
Impact of mode of training and recertification on ALSFRS-R rater performance
Jenny Hamilton, Praveena Mohan, Gale Kittle, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revised
Jeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
Muscle & Nerve
|
June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial
Eric A Macklin, James D Berry, Brittney A Harkey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Muscle & Nerve
|
May 27, 2025
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial
Brittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA
|
March 11, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, James D Berry, Nicholas J Maragakis, et al.
JAMA Neurology
|
March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial
, Jinsy Andrews, Sabrina Paganoni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 23, 2022
Impact of mode of training and recertification on ALSFRS-R rater performance
Jenny Hamilton, Praveena Mohan, Gale Kittle, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 20, 2023
Harmonized standard operating procedures for administering the ALS functional rating scale-revised
Jeremy M Shefner, Tommy Bunte, Gale Kittle, et al.
Muscle & Nerve
|
June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial
Eric A Macklin, James D Berry, Brittney A Harkey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Muscle & Nerve
|
May 27, 2025
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial
Brittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine
|
September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Muscle & Nerve
|
October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
JAMA
|
March 11, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
, James D Berry, Nicholas J Maragakis, et al.
JAMA Neurology
|
March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial
, Jinsy Andrews, Sabrina Paganoni, et al.
Page
of 2